# Assessment of the Pharmacokinetics and Safety of ANT3310 Combined With Meropenem in Renally Impaired Subjects

> **NCT06527677** · PHASE1 · COMPLETED · sponsor: **Antabio** · enrollment: 41 (actual)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** ANT3310
- **DRUG:** Meropenem

## Key facts

- **NCT ID:** NCT06527677
- **Lead sponsor:** Antabio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-19
- **Primary completion:** 2025-07-03
- **Final completion:** 2025-07-10
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2025-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06527677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06527677, "Assessment of the Pharmacokinetics and Safety of ANT3310 Combined With Meropenem in Renally Impaired Subjects". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06527677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*